Literature DB >> 33322582

Exploring Herbal Medicine Use during Palliative Cancer Care: The Integrative Physician as a Facilitator of Pharmacist-Patient-Oncologist Communication.

Noah Samuels1,2, Eran Ben-Arye2,3.   

Abstract

Oncology patients frequently use herbal and other forms of complementary medicine, often without the knowledge of oncologists, pharmacists, and other healthcare professionals responsible for their care. Oncology healthcare professionals may lack the knowledge needed to guide their patients on the safe and effective use of herbal medicinal products, a number of which have potentially harmful effects, which include direct toxicity and negative herb-drug interactions. The current review addresses the prevalence and expectations of oncology patients from herbal medicine, as well as evidence for the beneficial or harmful effects of this practice (potential and actual), especially when the herbal products are used in conjunction with anticancer agents. Models of integrative oncology care are described, in which open and effective communication among oncologists, pharmacists, and integrative physicians on the use of herbal medicine by their patients occurs. This collaboration provides patients with a nonjudgmental and multidisciplinary approach to integrative medicine, echoing their own health-belief models of care during conventional cancer treatments. The role of the integrative physician is to facilitate this process, working with oncologists and pharmacists in the fostering of patient-centered palliative care, while ensuring a safe and effective treatment environment. Case scenario: W. is a 56 year old female artist who was recently diagnosed with localized hormone receptor-positive breast cancer. Following lumpectomy and sentinel node dissection, she is scheduled to begin adjuvant chemotherapy with a regimen which will include adriamycin, cyclophosphamide, and paclitaxel (AC-T protocol). She is worried about developing peripheral neuropathy and its impact on her ability to paint, and she asks about a number of dietary supplements which she heard could prevent this from happening: omega-3, vitamin E, alpha-lipoic acid, and acetyl-l-carnithine. She is concerned, however, that the supplements may negatively interact with her chemotherapy regimen.

Entities:  

Keywords:  complementary and integrative medicine; herb-drug interaction; herbal medicine; integrative physician; multidisciplinary approach; oncology; pharmacist; safety

Year:  2020        PMID: 33322582      PMCID: PMC7763590          DOI: 10.3390/ph13120455

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  73 in total

Review 1.  Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings.

Authors:  Jingjing Yu; Zhu Zhou; Jessica Tay-Sontheimer; René H Levy; Isabelle Ragueneau-Majlessi
Journal:  J Pharm Sci       Date:  2017-04-13       Impact factor: 3.534

Review 2.  Integrating complementary medicine in supportive cancer care models across four continents.

Authors:  Eran Ben-Arye; Elad Schiff; Catherine Zollman; Peter Heusser; Pablo Mountford; Moshe Frenkel; Gil Bar-Sela; Ofer Lavie
Journal:  Med Oncol       Date:  2013-02-23       Impact factor: 3.064

3.  A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy.

Authors:  J Konmun; K Danwilai; N Ngamphaiboon; B Sripanidkulchai; A Sookprasert; S Subongkot
Journal:  Med Oncol       Date:  2017-03-27       Impact factor: 3.064

Review 4.  Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?

Authors:  M Del Re; V Citi; S Crucitta; E Rofi; F Belcari; R H van Schaik; R Danesi
Journal:  Pharmacol Res       Date:  2016-04-08       Impact factor: 7.658

5.  Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Authors:  Masashi Kanai; Atsushi Imaizumi; Yoshihiko Otsuka; Hiroki Sasaki; Momo Hashiguchi; Kazu Tsujiko; Shigemi Matsumoto; Hiroshi Ishiguro; Tsutomu Chiba
Journal:  Cancer Chemother Pharmacol       Date:  2011-05-21       Impact factor: 3.333

Review 6.  Wedding Rigorous Scientific Methodology and Ancient Herbal Wisdom to Benefit Cancer Patients: The Development of PHY906.

Authors:  Edward Chu
Journal:  Oncology (Williston Park)       Date:  2018-02-15       Impact factor: 2.990

Review 7.  Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.

Authors:  Esther L Davis; Byeongsang Oh; Phyllis N Butow; Barbara A Mullan; Stephen Clarke
Journal:  Oncologist       Date:  2012-08-29

8.  A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older.

Authors:  Tessa K Morgan; Margaret Williamson; Marie Pirotta; Kay Stewart; Stephen P Myers; Joanne Barnes
Journal:  Med J Aust       Date:  2012-01-16       Impact factor: 7.738

9.  Effects of St. John's wort on irinotecan metabolism.

Authors:  Ron H J Mathijssen; Jaap Verweij; Peter de Bruijn; Walter J Loos; Alex Sparreboom
Journal:  J Natl Cancer Inst       Date:  2002-08-21       Impact factor: 13.506

10.  The prevalence and experience of Australian naturopaths and Western herbalists working within community pharmacies.

Authors:  Lesley A Braun; Ondine Spitzer; Evelin Tiralongo; Jenny M Wilkinson; Michael Bailey; Susan Poole; Michael Dooley
Journal:  BMC Complement Altern Med       Date:  2011-05-23       Impact factor: 3.659

View more
  2 in total

1.  Efficacy of Herbal Medicines Intervention for Colorectal Cancer Patients With Chemotherapy-Induced Gastrointestinal Toxicity - a Systematic Review and Meta-Analysis.

Authors:  Yuanyuan Chen; Chien-Shan Cheng; Hor-Yue Tan; Chi Wing Tam; Ning Wang; Yibin Feng
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 2.  Drug-Herb Interactions among Thai Herbs and Anticancer Drugs: A Scoping Review.

Authors:  Apisada Jiso; Phisit Khemawoot; Pinnakarn Techapichetvanich; Sutinee Soopairin; Kittiphong Phoemsap; Panrawee Damrongsakul; Supakit Wongwiwatthananukit; Pornpun Vivithanaporn
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.